High-Density Lipoprotein Cholesterol, High-Density Lipoprotein Particle Size, and Apolipoprotein A-I: Significance for Cardiovascular Risk

van der Steeg, Wim A., Holme, Ingar, Boekholdt, S. Matthijs, Larsen, Mogens Lytken, Lindahl, Christina, Stroes, Erik S.G., Tikkanen, Matti J., Wareham, Nicholas J., Faergeman, Ole, Olsson, Anders G., Pedersen, Terje R., Khaw, Kay-Tee, Kastelein, John J.P.·2008·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2007.09.060

Cited by (374)

Items 201–300 of 374

  1. Role of food matrix in modulating dairy fat induced changes in lipoprotein particle size distribution in a human intervention
    Simone Dunne, Fiona C. McGillicuddy, Eileen R. Gibney, Emma L. Feeney · 2022 · American Journal of Clinical Nutrition
  2. Association of the Monocyte to High-Density Lipoprotein Cholesterol Ratio and Neutrophil to High-Density Lipoprotein Cholesterol Ratio With the Severity of New-Onset Coronary Artery Disease
    Hongyun Shu, Sisi Han, Weiping Qiu, Jianhong Li, Xiao‐Yong Zhang, Hui Fang Su, Hongjie Wu, Guojun Zhao, Qiaowen Li · 2025 · Journal of Inflammation Research
  3. HDL: To Treat or Not To Treat?
    Angela Pirillo, Gianpaolo Tibolla, Giuseppe Danilo Norata, Alberico Luigi Catapano · 2014 · Current Atherosclerosis Reports
  4. Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy
    Peter Paul Toth, William Insull, Robert J. Padley, Rhea Angela N Parreño, Ping X. Jiang, Thakkar, Scott L. Krause, H. Robert Superko · 2010 · Vascular Health and Risk Management
  5. Role of High-Density Lipoprotein Cholesterol (HDL-C) as a Clinical Predictor of Decompensation in Patients with Chronic Liver Disease (CLD)
    Harshavardhan B. Rao, Priya Nair, Anoop K. Koshy, Sanjeev Krishnapriya, Greeshma C. Ravindran, Rama P. Venu · 2021 · International Journal of Hepatology
  6. Common variation in Cholesteryl Ester Transfer Protein: Relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio
    Paul J.W.H. Kappelle, Ron T. Gansevoort, Hans L. Hillege, Bruce H. R. Wolffenbuttel, Robin P. F. Dullaart · 2012 · Journal of clinical lipidology
  7. High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease
    Guoliang Chen, Liwei Liu, Shuang Xie, Hong Shu Liu, Yuqing Liu, Yishi Li · 2010 · Chinese Medical Journal
  8. The Future of Lipid-Lowering Therapy
    Willemien Heerema-van Zwol, Antoine Rimbert, Jan Albert Kuivenhoven · 2019 · Journal of Clinical Medicine
  9. Effect of High-Density Lipoprotein Cholesterol Levels on Overall Survival and Major Adverse Cardiovascular and Cerebrovascular Events
    Manpreet Kaur, Keerat Rai Ahuja, Shameer Khubber, Leon Zhou, Beni Rai Verma, Chandramohan Meenakshisundaram, Mohamed M. Gad, Anas M. Saad, Kamalpreet Dhaliwal, Toshiaki Isogai et al. · 2021 · The American Journal of Cardiology
  10. Viability of Developing CETP Inhibitors
    Cesare Riccardo Sirtori, Giuliana Germana Mombelli · 2008 · Cardiovascular Therapeutics
  11. Lipid transfer to high‐density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events
    Carlos Barbosa, Raul Cavalcante Maranhão, Renata S. Barreiros, Fatima Rodrigues Freitas, André Franci, Célia Maria Cássaro Strunz, Flávia Bittar Britto Arantes, Thauany Martins Tavoni, José Antônio Franchini Ramires, Roberto Kalil Filho et al. · 2019 · Clinical Cardiology
  12. Human variant of scavenger receptor BI (R174C) exhibits impaired cholesterol transport functions
    Sarah C. May, Jacqueline S. Dron, Robert Alexander Hegele, Daisy Sahoo · 2021 · Journal of Lipid Research
  13. Particle numbers of lipoprotein subclasses and arterial stiffness among middle-aged men from the ERA JUMP study
    Abhishek Vishnu, Jina Choo, Kamal Masaki, Rachel H. Mackey, Emma Barinas‐Mitchell, Chol Shin, Bradley J. Willcox, Aiman El‐Saed, Todd B. Seto, Akira Fujiyoshi et al. · 2013 · Journal of Human Hypertension
  14. Ruminant-Produced trans-Fatty Acids Raise Plasma HDL Particle Concentrations in Intact and Ovariectomized Female Hartley Guinea Pigs
    Beth H. Rice, Jana Kraft, Frédéric Destaillats, Dale Elton Bauman, A.L. Lock · 2012 · Journal of Nutrition
  15. Increased Apolipoprotein AI Production Rate and Redistribution of High-Density Lipoprotein Size Induced by Estrogen plus Progestin as Oral Contraceptive
    Laurence Duvillard, Guillaume Dautin, Emmanuel Florentin, Aline Jeannin, Jean-Paul Paı̈s de Barros, Laurent Lagrost, Jean‐Michel Petit, Philippe Gambert, Bruno L Vergès · 2009 · The Journal of Clinical Endocrinology & Metabolism
  16. The Buffering Role of HDL in Balancing the Effects of Hypercoagulable State in Type 2 Diabetes
    Maysam Mard‐Soltani, Mohammad Reza Dayer, Abdolhosein Shamshirga, Hamid Ali-Bahar, Zahra Nasirbaghe · 2012 · Journal of Applied Sciences
  17. Klinische Bedeutung des HDL-Cholesterins
    Winfried März, Marcus Edi Kleber, Hubert Scharnagl, Thimoteus Speer, Stephen Zewinger, Andreas Ritsch, Klaus Georg Parhofer, Arnold von Eckardstein, Ulf Landmesser, Ulrich Laufs · 2016 · Herz
  18. Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop
    Annabelle Rodríguez, Bernardo L. Trigatti, Chieko Mineo, Darcy A. Knaack, John T. Wilkins, Daisy Sahoo, Bela F. Asztalos, Samia Mora, Marina Cuchel, Henry J. Pownall et al. · 2019 · Arteriosclerosis Thrombosis and Vascular Biology
  19. Perspective The failure of cholesteryl ester transfer protein inhibitors: is it due to increased blood viscosity?
    Gregory D. Sloop, Joseph J. Weidman, John A. St. Cyr · 2015 · Therapeutic Advances in Cardiovascular Disease
  20. Early Midlife Cardiovascular Health Influences Future HDL Metrics in Women: The SWAN HDL Study
    Alexis Nasr, Karen A. Matthews, Maria M. Brooks, Emma Barinas‐Mitchell, Trevor John Orchard, J T Billheimer, Norman C. Wang, Daniel S McConnell, Daniel James Rader, Samar R. El Khoudary · 2022 · Journal of the American Heart Association
  21. Reversal of atherosclerosis with apolipoprotein A1: Back to basics
    Loek P. Smits, Ruud S. Kootte, Erik S.G. Stroes · 2013 · Atherosclerosis
  22. Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients
    Baohai Shao, Farsad Afshinnia, Anna Vachaparampil Mathew, Graziella E. Ronsein, Carissa Thornock, Angela D. Irwin, Mayank Mohan Kansal, Panduranga S. Rao, Mirela A. Dobre, Sadeer G Al-Kindi et al. · 2023 · Journal of Lipid Research
  23. Dysfunctional HDL and Cardiovascular Disease Risk in Individuals with Diabetic Dyslipidemia
    Omeed Elboudwarej, Houmehr Hojjat, Shila Safarpoor · 2012 · Journal of Diabetes & Metabolism
  24. Association of cardiovascular events and lipoprotein particle size: Development of a risk score based on functional data analysis
    Charles M. Rowland, Dov Shiffman, Michael P. Caulfield, Veronica Garcia, Olle Melander, Trevor J. Hastie · 2019 · PLoS ONE
  25. Further proof of a paradoxical relationship between high-density lipoprotein levels and adverse cardiovascular outcomes: are there implications for cardiovascular disease prevention?
    Setor Kwadzo Kunutsor, Jari Antero Laukkanen · 2022 · European Journal of Preventive Cardiology
  26. Relationship of high‐density lipoprotein subfractions and apolipoprotein A‐I with fat in the pancreas
    Yutong Liu, Xiatiguli Shamaitijiang, Loren Skudder‐Hill, Wandia Kimita, Ivana Roosevelt Sequeira, Maxim S. Petrov · 2024 · Diabetes Obesity and Metabolism
  27. High-density lipoproteins. Part 2. Impact of disease states on functionality
    Anna Gluba-Brzózka, Robert Olszewski, Beata Franczyk, Ewelina Młynarska, Magdalena Rysz-Górzyńska, Jacek Rysz, Stanisław Surma, Sohum Sheth, Maciej Banach, Peter Paul Toth · 2025 · American Journal of Preventive Cardiology
  28. The association between early pregnancy maternal lipid indicators with gestational diabetes mellitus and pre-eclampsia
    Jiapeng Tang, Ye Chen, Mengting Sun, Manjun Luo, Yige Chen, Kebin Chen, Qi Zou, Yuan Peng, Tingting Wang, Jiabi Qin · 2025 · Journal of Lipid Research
  29. Safety of Subcutaneous Piperacillin/Tazobactam Administration Compared to Intravenous Administration: Propensity Score–Matched Cohort Study
    Daiki Kobayashi, Misuzu Cho, Kyoko Yokota, Takuro Shimbo · 2019 · Journal of the American Medical Directors Association
  30. Both LDL and HDL particle concentrations associate positively with an increased risk of developing microvascular complications in patients with type 2 diabetes: lost protection by HDL (Zodiac-63)
    Arno R. Bourgonje, Margery A. Connelly, Harry van Goor, Peter Ruben van Dijk, Robin P. F. Dullaart · 2023 · Cardiovascular Diabetology
  31. The Association of Elevated HDL Levels With Carotid Atherosclerosis in Middle-Aged Women With Untreated Essential Hypertension
    Helen Triantafyllidi, George Pavlidis, Paraskevi Trivilou, Ignatios Ikonomidis, Stavros Tzortzis, Iosif Xenogiannis, Antonios Schoinas, John P Lekakis · 2015 · Angiology
  32. Exploring the link between scavenger receptor B1 expression and chronic obstructive pulmonary disease pathogenesis
    Giuseppe Valacchi, Emanuela Maioli, Claudia Sticozzi, Franco Cervellati, Alessandra Pecorelli, Carlo Cervellati, Joussef Hayek · 2015 · Annals of the New York Academy of Sciences
  33. Sex-specific predictors of the prehypertension-to-hypertension progression: community-based cohort of a West-Asian population
    Mohammadreza Bozorgmanesh, Hadi Ghoreishian, Reza Mohebi, Fereidoun Azizi, Farzad Hadaegh · 2013 · European Journal of Preventive Cardiology
  34. New Concepts in the Diagnosis and Non-Surgical Treatment of Cardiovascular Disease
    Mark C. Houston · 2013 · Internal Medicine Open Access
  35. High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels
    Beata Franczyk, Ewelina Młynarska, Magdalena Rysz-Górzyńska, Anna Gluba-Brzózka, Jacek Rysz, Sohum Sheth, Stanisław Surma, Maciej Banach, Peter Paul Toth · 2025 · American Journal of Preventive Cardiology
  36. Associations of Abdominal and Cardiovascular Adipose Tissue Depots With HDL Metrics in Midlife Women: the SWAN Study
    Alexis Nasr, Karen A. Matthews, İmke Janssen, Maria M. Brooks, Emma Barinas‐Mitchell, Trevor John Orchard, Jeffrey T. Billheimer, Norman C. Wang, Daniel S McConnell, Daniel James Rader et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
  37. The Ratio of High‐Density Lipoprotein Cholesterol to Apolipoprotein A‐I Predicts Myocardial Injury Following Elective Percutaneous Coronary Intervention
    Xiaolin Li, Jian‐Jun Li, Yuan‐Lin Guo, Cheng‐Gang Zhu, Ping Qing, Na‐Qiong Wu, Bo Xu, Run‐Lin Gao · 2014 · Clinical Cardiology
  38. Association of ApoE and HDL.C with cardiovascular and cerebrovascular disease: potential benefits of LDL-apheresis therapy
    Patrick M. Moriarty · 2009 · Clinical Lipidology
  39. Alcohol Consumption, High-Density Lipoprotein Particles and Subspecies, and Risk of Cardiovascular Disease: Findings from the PREVEND Prospective Study
    S. Kunutsor, Atanu Bhattacharjee, M. Connelly, S. J. Bakker, R. Dullaart · 2024 · International Journal of Molecular Sciences
  40. Niveles plasmáticos de apolipoproteínas en una población saludable de la Argentina: implicaciones en prevención cardiovascular
    Daniel Alberto Siniawski, Walter M. Masson, Ignacio Martin Bluro, Patricia Beatriz Sorroche, Walter Scordo, Juan G. Krauss, Arturo M. Cagide · 2025 · Revista Argentina de Cardiología
  41. High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes
    Martin Heier, Anne Pernille Ofstad, Mark S. Borja, Cathrine Brunborg, Knut Endresen, Lars Lysgaard Gullestad, Kåre I. Birkeland, Odd Erik Johansen, Michael N. Oda · 2018 · Atherosclerosis
  42. High density lipoprotein cholesterol and proteome in SR-B1 KO mice: lost in precipitation
    Susana Contreras‐Duarte, Nicolas G. Santander, Ruth Birner‐Gruenberger, Christian Wadsack, Attilio Rigotti, Dolores Busso · 2018 · Journal of Translational Medicine
  43. Anacetrapib: new hope for cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia
    Menno Vergeer, John J.P. Kastelein · 2008 · Nature Clinical Practice Cardiovascular Medicine
  44. Coronary Artery Disease with Elevated Levels of HDL Cholesterol Is Associated with Distinct Lipid Signatures
    Wanying Xia, Haiyi Yu, Guisong Wang · 2023 · Metabolites
  45. Association between high-density lipoprotein cholesterol to apolipoprotein A ratio and diabetic retinopathy: A cross-sectional study
    Cong Zhang, Wenjian Lin, Qian Xu, Hongxue Li, Chengye Xu, Xuefei Ma, Ming Hao, Hongyu Kuang · 2023 · Journal of Diabetes and its Complications
  46. Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9
    Renato Quispe, Mohammed Ahmad Al-Hijji, Kristopher J. Swiger, Seth Shay Martin, Mohamed Badreldin Elshazly, Michael Joseph Blaha, Parag H. Joshi, Roger Scott Blumenthal, Allan D. Sniderman, Peter Paul Toth et al. · 2015 · Journal of clinical lipidology
  47. Statin Treatment Improves Plasma Lipid Levels but not HDL Subclass Distribution in Patients Undergoing Percutaneous Coronary Intervention
    Li Tian, Yucheng Chen, Chuanwei Li, Zhi Zeng, Yanhua Xu, Shiyin Long, Mingde Fu · 2012 · Lipids
  48. Prediction of Cardiovascular Events in Patients with Ankylosing Spondylitis and Psoriatic Arthritis: Role of Lipoproteins in a High-risk Population
    Anne Grete Semb, Tore Kristian Kvien, David A. DeMicco, Rana S. Fayyad, Chuan‐Chuan Wun, John C. LaRosa, John D. Betteridge, Terje Rolf Pedersen, Ingar Holme · 2012 · The Journal of Rheumatology
  49. Dyslipidemia in Obesity
    Dick C. Chan, Jing Pang, Gerald Francis Watts · 2016 · Springer eBooks
  50. Health aspects of saturated fatty acids
    Jan Ivar Pedersen, Bente Kirkhus · 2011 · Elsevier eBooks
  51. Clinical value of Lp-PLA2, LDL-C, HDL-C, hs-CRP, leukocyte, FPG and HbA1c in type 2 diabetes mellitus patients with acute ischemic stroke
    Huimin Shen, Anyan Huang, Bingxin Wang, Xiaohua Huang, Ruiqian Chen · 2025 · Frontiers in Endocrinology
  52. Association Between Cumulative Exposure to Increased Low-Density Lipoprotein Cholesterol and the New Occurrence of Peripheral Artery Disease
    Xinmin Liu, Yu Wang, Jianwei Wu, Anxin Wang, Xiaoli Zhang, Zhentang Cao, Xingquan Zhao · 2021 · Frontiers in Neurology
  53. Genetic Determinants of Visit-to-Visit Lipid Variability: Genome-Wide Association Study in Statin-Naïve Korean Population
    Jun‐Bean Park, Eun‐Soon Shin, Jong-Eun Lee, Seung Jae Lee, Heesun Lee, Su‐Yeon Choi, Eun Kyung Choe, Seung Ho Choi, Hyo Eun Park · 2022 · Frontiers in Cardiovascular Medicine
  54. Excessive Consumption of Alcoholic Beverages and Extremely High Levels of High-Density Lipoprotein Cholesterol (HALP) in the ELSA-Brasil Cohort Baseline
    Oscar Geovanny Enríquez Martínez, Taísa Sabrina Silva Pereira, José Geraldo Mill, Maria de Jesus Mendes da Fonseca, María del Carmen Bisi Molina, Rosane Härter Griep · 2023 · Nutrients
  55. A Novel Relative High-Density Lipoprotein Index to Predict the Structural Changes in High-Density Lipoprotein and Its Ability to Inhibit Endothelial–Mesenchymal Transition
    Feng‐Yen Lin, Yi‐Wen Lin, Chun‐Ming Shih, Shing‐Jong Lin, Yu‐Tang Tung, Chi‐Yuan Li, Yung‐Hsiang Chen, Cheng-Yen Lin, Yi-Ting Tsai, Chun‐Yao Huang · 2021 · International Journal of Molecular Sciences
  56. High-density lipoprotein cholesterol to apolipoprotein A1 ratio and all-cause mortality among incident peritoneal dialysis patients
    Chuanfei Zeng, Caixia Yan, Shan Guo, Hengmei Zhu, Yanbing Chen, Xiaojiang Zhan · 2021 · Nutrition Metabolism and Cardiovascular Diseases
  57. Design, Synthesis, Computational and Biological Evaluation of Novel Structure Fragments Based on Lithocholic Acid (LCA)
    Jiangling Peng, Mingjie Fan, Kelly X. Huang, Lina A. Huang, Yangmeng Wang, Runkai Yin, Hanyi Zhao, Senlin Xu, Hongzhi Li, Alon Agua et al. · 2023 · Molecules
  58. Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease?
    Martin Whyte · 2019 · JRSM Cardiovascular Disease
  59. Moving beyond LDL-C: incorporating lipoprotein particle numbers and geometric parameters to improve clinical outcomes
    Thomas D. Dayspring, Dall, Abuhajir · 2010 · Research Reports in Clinical Cardiology
  60. High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease
    Anna Vachaparampil Mathew, Yun Jae Han, Vetalise K. Cheofor, Yanhong Guo, Jaeman Byun, Alexander George, Julian Meza, Sanjay Rajagopalan, Y. Eugene Chen, Brenda W. Gillespie et al. · 2025 · PLoS ONE
  61. AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
    Naila Rabbani · 2022 · International Journal of Molecular Sciences
  62. Labordiagnostik von Fettstoffwechselstörungen
    Winfried März, Hubert Scharnagl, Marcus Edi Kleber, Günther Silbernagel, Matthias Nauck, Dirk Müller‐Wieland, Arnold von Eckardstein · 2023 · DMW - Deutsche Medizinische Wochenschrift
  63. Hypertensive Disorders of Pregnancy: Assessing the Significance of Lp(a) and ApoB Concentrations in a Romanian Cohort
    Simona-Alina Abu-Awwad, Marius Lucian Craina, Lioara Boscu, Elena Silvia Bernad, Paula Diana Ciordas, Cătălin Marian, Mircea Iurciuc, Ahmed Abu-Awwad, Stela Iurciuc, Brenda-Cristiana Bernad et al. · 2023 · Journal of Personalized Medicine
  64. Impact of estimated HDL particle size via the ratio of HDL-C and apoprotein A-I on short-term prognosis of diabetic patients with stable coronary artery disease.
    Li-Feng Hong, Bo Yang, Song-Hui Luo, Jian‐Jun Li · 2014 · Europe PMC (PubMed Central)
  65. Cholesterol Efflux Capacity
    Winfried März, Andreas Ritsch · 2016 · Journal of the American College of Cardiology
  66. Modified risk associations of lipoproteins and apolipoproteins by chronic low-grade inflammation
    Altan Onat, Ayşem Kaya, Evin Ademoğlu · 2017 · Expert Review of Cardiovascular Therapy
  67. Tobacco Smoke Exposure Reduces Paraoxonase Activity in a Murine Model
    Robert M. Reed, Saif Borgan, Michael H. Eberlein, Monica P. Goldklang, Joshua P. Lewis, Michael J. Miller, Mohamad Navab, Bo Kim · 2017 · International Journal of Biomedical Science
  68. Plasma Cholesteryl Ester Transfer Protein (CETP) in Relation to Human Pathophysiology
    Akihiro Inazu · 2010 · Elsevier eBooks
  69. The ENHANCE Study: an unusual publication of trial data raises questions beyond ezetimibe
    Keith E. Suckling · 2008 · Expert Opinion on Pharmacotherapy
  70. HDL – a difficult friend
    Arnold von Eckardstein · 2008 · Drug Discovery Today Disease Mechanisms
  71. Single‐Nucleotide Polymorphisms in the TNF Gene Are Associated With Obesity‐Related Phenotypes in Vervet Monkeys
    Stanton B. Gray, Carl D. Langefeld, Julie T. Ziegler, Gregory A. Hawkins, Janice D. Wagner, Timothy D. Howard · 2011 · Obesity
  72. Lipid lowering in diabetes mellitus
    D. J. Betteridge · 2008 · Current Opinion in Lipidology
  73. High-Density Lipoprotein Cardioprotection Function Deteriorates as Women Transition Through Menopause
    Samar R. El Khoudary, James Matuk, Maria M. Brooks, Daniel S McConnell, Sybil L. Crawford, Ziyuan Wang, İmke Janssen, Daniel James Rader · 2025 · JACC Advances
  74. Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics
    Tereza Altschmiedová, Veronika Todorovová, Michal Vrablı́k, R Češka · 2022 · Frontiers in Genetics
  75. Genome Editing in Dyslipidemia and Atherosclerosis
    Zhifen Chen, Constanze Lehertshuber, Heribert Schunkert · 2022 · Advances in experimental medicine and biology
  76. The Association of the Levels of High-Density Lipoprotein and Apolipoprotein A1 with SARS-CoV-2 Infection and COVID-19 Severity: An Analysis of the N3C Database
    Menghao Li, Rajendra Kulkarni, Naoru Koizumi, Ali Andalibi · 2023 · Biology
  77. Lipoprotein profile assessed by 1H NMR, BMI and blood pressure are associated with vascular alterations in children with familial hypercholesterolaemia
    Dolors Llop, Albert Feliu, Daiana Ibarretxe, Joaquín Escribano, Núria Plana, Cèlia Rodríguez-Borjabad, L. Masana, Joan-Carles Vallvé · 2023 · Nutrition Metabolism and Cardiovascular Diseases
  78. Association of lipoprotein subclasses and carotid intima-media thickness in the Chinese population
    Fangfang Yan, Li Tian, Huangdao Yu, Attit Baskota, Yun Gao, Sheyu Li, Mingde Fu, Haoming Tian · 2014 · Clinical Lipidology
  79. Dyslipidemia in Obesity
    Dick C. Chan, Jing Pang, Gerald Francis Watts · 2015 · Springer eBooks
  80. Functional diversity of high-density lipoproteins: finding the golden mean
    Victoria A. Metelskaya · 2021 · Ateroscleroz
  81. 1H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls
    Albert Teis, Esmeralda Castelblanco, Germán Cediel, Núria Amigó, Josep Julve, Josep Ribalta, Montse Guardiola, Josep Franch‐Nadal, Marcelino Bermúdez-López, Pau Codina et al. · 2021 · Revista Española de Cardiología (English Edition)
  82. The correlation of apolipoprotein B, apolipoprotein B/apolipoprotein A-I ratio and lipoprotein(a) with myocardial infarction
    Lucia Agoşton-Coldea, Teodora Mocan, Marc Gatfossé, Dan Lucian Dumitrascu · 2008 · Open Medicine
  83. Linear reverse risk of HDL-C levels for predicting cardiovascular disease: it is not that straightforward!
    Ragavendra R. Baliga, Eric H. Yang, Eduardo Bossone · 2020 · European Journal of Preventive Cardiology
  84. Interaction of common sequence variants and selected risk factors in determination of HDL cholesterol levels
    Kateřina Hirschfeldová, Sedova Michaela, Michal Vrablík, Svobodova Helena, Jana Zvárová, Jaroslav Alois Hubacek, R Češka · 2010 · Clinical Biochemistry
  85. Association of HDL Cholesterol with Incident Cardiovascular Events by LDL Cholesterol and Apolipoprotein B100 in Women
    Samia Mora, Julie E. Buring, Paul M. Ridker, Yadong Adam Cui · 2011 · Annals of Internal Medicine
  86. Large high-density lipoprotein particle number is independently associated with microvascular function in patients with well-controlled low-density lipoprotein concentration: A vasodilator stress magnetic resonance perfusion study
    Akhil Narang, Victor Mor‐Avi, Nicole Martin Bhave, Giacomo Tarroni, Cristiana Corsi, Michael H. Davidson, Roberto Miguel Lang, Amit R. Patel · 2015 · Journal of clinical lipidology
  87. Novel bioactive lipids enhanced HDL-mediated cholesterol efflux from macrophages through the ABCA1 receptor pathway
    Ali Khattib, Manar Shmet, Rasha Ashkar, Tony Hayek, Soliman Khatib · 2023 · Chemistry and Physics of Lipids
  88. CETP antagonism versus agonism in cardiovascular prevention and plaque regression
    Cesare Riccardo Sirtori, Giuliana Germana Mombelli · 2009 · Clinical Lipidology
  89. The unresolved mystery of high-density lipoprotein: time for a paradigm shift?
    Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund · 2016 · Translational research
  90. The High Density Lipoprotein Cholesterol Hypothesis Revisited
    Anna Meiliana, Nurrani Mustika Dewi, Andi Wijaya · 2018 · The Indonesian Biomedical Journal
  91. Clinical biomarkers of high-density lipoprotein dysfunction among middle-aged Turks
    Altan Onat, Günay Can, Sani Namık Murat, Gökhan Çiçek, Ender Örnek, Hüsniye Yüksel · 2012 · The Anatolian Journal of Cardiology
  92. Associations of high-density lipoprotein cholesterol, particles and subspecies with the risk of hypertension: findings from the PREVEND prospective study
    Setor Kwadzo Kunutsor, Margery A. Connelly, Ashish H. Shah, Stephan J. L. Bakker, Robin P. F. Dullaart · 2025 · Journal of Hypertension
  93. Which shoud be the goals of apolipoprotein A1? Analysis of a healthy population in Argentina
    Walter M. Masson, Daniel Alberto Siniawski, Patricia Beatriz Sorroche, Walter Scordo · 2012 · Revista Argentina de Cardiología
  94. Association of dyslipidemia with vasospastic angina
    Li-Feng Hong, Song-Hui Luo, Jian‐Jun Li · 2014 · Chinese Medical Journal
  95. Comparison of Lipid Profile Components in Different Degrees of Age-Related Macular Degeneration in Northern Part of Iran
    Khadijeh Ezoji, Fatemeh Firouzmandi, Ebrahim Mikaniki, Reza Ghadimi, Seyed Reza Hosseini, Ali Bijani, GholamAbbas Roustaei, Mehrnoosh Ghasemi, Seyed Ahmad Rasoulinejad · 2022 · Shiraz E-Medical Journal
  96. High-density lipoprotein cholesterol to apolipoprotein A-1 ratio is an important indicator predicting in-hospital death in patients with acute coronary syndrome
    Zhenjun Ji, Guiren Liu, Rui Zhang, Abdlay Carvalho, Jiaqi Guo, Wenjie Zuo, Xiaoguo Zhang, Yangyang Qu, Jie Lin, Ziran Gu et al. · 2022 · Cardiology Journal
  97. The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis
    José A. Quesada, Vicente Bertomeu‐González, Domingo Orozco‐Beltrán, Alberto Cordero, Vicente Francisco Gil-Guillén, Adriana López‐Pineda, Rauf Nouni-García, Concepción Carratalá‐Munuera · 2023 · Clínica e Investigación en Arteriosclerosis (English Edition)
  98. Impaired Cholesterol Uptake Capacity in Patients with Hypertriglyceridemia and Diabetes Mellitus
    Yutaro Seto, Manabu Nagao, Takuya Iino, Amane Harada, Katsuhiro Murakami, Keiko Miwa, Masakazu Shinohara, Makoto Nishimori, Sachiko Yoshikawa, Junko Asakura et al. · 2024 · The Journal of Applied Laboratory Medicine
  99. Dynamics of HDL-Cholesterol Following a Post-Myocardial Infarction Cardiac Rehabilitation Program
    Carlos Bertolín‐Boronat, Hector Merenciano-Gonzalez, Víctor Marcos‐Garcés, María Luz Martínez Mas, Josefa Inés Climent Alberola, Nerea Pérez-Solé, Laura López, María Concepción Esteban Argente, María Valls Reig, Ana Arizón Benito et al. · 2025 · Reviews in Cardiovascular Medicine
  100. Rosuvastatin reduces expression of tissue factor through inhibiting RhoA/ROCK pathway to ameliorate atherosclerosis
    Jingwei Zhou, Guangjie Yin, Tao Yu, Yubao Zhang, Xintao Tian, Di Xia, Lei Shi · 2021 · Panminerva Medica